Unfortunately, no clinical predictive factor has been clearly identified yet, except for FCGR2B*232T polymorphisms, associated with a poor response to IVIg in children with ITP [28]. The gene discussed is FCGR2B; the disease is autoimmune thrombocytopenic purpura.